GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation unjustified. See what to expect from GSK's Q3.
Caving to online male backlash that included a threatened boycott, Chinese e-commerce giant JD.com announced that it would scrap its November 11 “Singles Day” shopping festival collaboration with ...
Andrew Sabori’s artwork “The Forgotten Mural” has been traveling around the country for about 16 years and is making its second stop in Albany at the Thronateeska Heritage Center Museums and ...